<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5090219 Figure_1-B</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Protein structural predictions for S. pombe Rbd2 (blue) and E. coli GlpG (red). Protein structures were predicted using the Phyre2 server (&lt;a href="http://www.sbg.bio.ic.ac.uk/phyre2"&gt;http://www.sbg.bio.ic.ac.uk/phyre2). Rbd2 model structure was aligned to GlpG using PyMOL.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_1-E</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 1-E</infon>
    <infon key="sourcedata_figure_dir">Figure_1-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Cells carrying a plasmid expressing rbd2-6xmCherry and either of two Golgi proteins dsc2-6xGFP (dsc2-6xGFP rbd2-6xmCherry) or Sec72-6xGFP (Sec72-6xGFP rbd2-6xmCherry) were imaged by confocal fluorescence microscopy.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_2-A</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Wild-type (WT), rbd2&#916; or sre1&#916; yeast (200 cells) containing either empty vector (EV) or a plasmid expressing sre1N (Sre1amino acids 1-440) were grown on rich medium in the presence or absence of cobalt chloride (CoCl2).</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_2-B</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Western blot was probed with anti-Sre1 IgG of phosphatase-treated, whole cell lysates from WT and the indicated mutants grown for the indicated time in the absence of oxygen. Dsc5 serves as a loading control and was detected by chemiluminescence. P and N denote Sre1 precursor and cleaved nuclear forms, respectively.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_2-C</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Indicated yeast strains expressing rbd2 or chromosomal Flag-tagged rbd2, rbd2-S130A or rbd2-H182A were analyzed for Sre1 cleavage. Western blot was performed using anti-Sre1 or anti-FlagIgG of phosphatase-treated, whole cell lysates from cells grown for 3 hr in the presence or absence of oxygen.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_2-D</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Indicated yeast strains expressing rbd2 or chromosomal Flag-tagged rbd2, rbd2-S130A or rbd2-H182A were analyzed for Sre2 cleavage by western blot probed with anti-Sre2 serum or anti-FlagIgG of phosphatase-treated, whole cell lysates from cells grown in the presence of oxygen.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_2-E</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Sre1 cleavage assay was performed as in (C). G128V, A127D and A186T mutant strains were obtained from our previous mutagenesis screening (Stewart et al, 2012). Dsc5 serves as a loading control.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_2-F</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Sre2 cleavage assay for indicated yeast strains was performed as in (D).</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_2-G</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 2-G</infon>
    <infon key="sourcedata_figure_dir">Figure_2-G</infon>
    <passage>
      <offset>0</offset>
      <text>G. A model substrate of Sre2 containing amino acids 423-793 (Sre2MS) with an N-terminal 3xFlag epitope tag was expressed on a plasmid under the control of a CaMV promoter in sre2&#916;, dsc1&#916;sre2&#916; or rbd2&#916;sre2&#916; yeast strains. Whole cell lysates from indicated yeast strains were analyzed by western blot with anti-Flag antibody. Three independent isolates (A-C) are shown for each strain. Empty vector (EV) transformation serves as a negative control.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_3-A</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Wild-type (WT) and the indicated mutant strains were grown for 3 hr at the non-permissive temperature (36&#176;C) to inactivate Mts3. Phosphatase-treated cell lysates were analyzed by western blot with anti-Sre2 serum and imaged using chemiluminescence. P and N denote Sre2 precursor and cleaved nuclear forms, respectively.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_3-B</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. WT, rbd2&#916; and sre2&#916; cells were treated with bortezomib (Bz) for 3 hr, and phosphatase-treated, whole cell lysates were analyzed by western blot with anti-Sre2 serum.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_3-C</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. WT, dsc1&#916; and rbd2&#916; cells carrying either empty vector (EV) or a plasmid expressing 3xFlag-Sre2MS (MS) were treated with bortezomib (Bz) for 3 hr. Whole cell lysates were analyzed by western blot with anti-Flag antibody.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_3-D</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Whole cell lysates from the indicated strains were analyzed by western blot with anti-Sre2 serum.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_3-E</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Catalytically dead Dsc1 E3 ligase (dsc1-C634A) mutant and other indicated yeast strains were analyzed by western blot probed with anti-Sre2 serum and imaged using chemiluminescence.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_4-A</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Human HEK293T cells were transfected with plasmids expressing different 3xHA-tagged rhomboid proteases: S. pombe rbd2, S. pombe rbd2 recoded for human expression, human RHBDL2, D. melanogaster Rho1, and P. falciparum ROM4. Whole cell lysates were analyzed by western blot to detect the HA-tagged rhomboid [asterisks indicate loading control bands detected with antibody ab179726 (abcam)].</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_4-B</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. HumanHEK293T cells were transfected with plasmids expressing the indicated rhomboid substrates and either recoded S. pombe rbd2, D. melanogaster Rho1, or P. falciparumROM4. Conditioned media and cell lysates were analyzed by western blot. P and C denote precursor and cleaved products, respectively.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_4-C</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Human HEK293T cells were transfected with plasmids expressing the GFP-TatA-Flag substrate and the indicated rhomboid proteases. Whole cell lysates were analyzed by western blot. P, CN, CC denote precursor, N-terminal cleaved and C-terminal cleaved products, respectively.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_4-D</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Human HEK293T cells were transfected with plasmids expressing the indicated GFP-TatA-Flag substrates and either wild-type or mutant recoded S. pombe rbd2. Whole cell lysates were analyzed by western blot.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_4-E</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 4-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Human HEK293T cells were transfected with plasmids expressing the indicated GFP-TatA-Flag substrates and different rhomboid proteases. Whole cell lysates were analyzed by western blot.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_4-F</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 4-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Human HEK293T cells were transfected with plasmids expressing the GFP-TatA (A8L)-Flag and recoded S. pombe rbd2. C-terminal cleavage products were purified using anti-Flag antibodies and purified protein was analyzed by mass spectrometry.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_5-B</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Whole cell lysates from WT, rbd2&#916; and dsc1&#916; cells carrying a plasmid expressing 3xFlag-Sre2MS WT or indicated mutants were analyzed by western blot with anti-Flag antibody. P and N denote Sre2MS precursor and cleaved forms, respectively.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_5-D-E</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 5-D-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D-E</infon>
    <passage>
      <offset>0</offset>
      <text>D-E. Whole cell lysates from WT, rbd2&#916; and dsc1&#916; cells carrying a plasmid expressing 3xFlag-Sre2MS WT or indicated mutants were analyzed by western blot with anti-Flag antibody. P and N denote Sre2MS precursor and cleaved forms, respectively. Asterisks indicate non-specific, loading control bands, which were used to normalize the intensities of P and N in Figure 5F. Two independent isolates, A and B, are shown for each strain.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_5-F</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Intensities of individual P and N bands from western blots were quantified using LI-COR software. Relative intensity of P and N to corresponding non-specific band (asterisk) in each lane was normalized to that of P level in isolate A of WT strain for each mutagenesis. The ratio of N to P or relative P level was presented in bar graphs.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_5-G</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 5-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G</infon>
    <passage>
      <offset>0</offset>
      <text>G. The average ratio of N to P level for different Sre2MS mutants in wild-type cells (Appendix Fig S2) was plotted. Cleavage was scored as normal if the ratio was &gt;2.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_5-H</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 5-H</infon>
    <infon key="sourcedata_figure_dir">Figure_5-H</infon>
    <passage>
      <offset>0</offset>
      <text>H. For Sre2MS mutants showing defects in cleavage, the average fold-increase in P level in dsc1&#916; cells compared to WT cells from two isolates (Appendix Fig S2) was plotted. Mutants were grouped into three phenotypic classes (intermediate, dsc1&#916;, and rbd2&#8710;) according to observed precursor accumulation. Precursor accumulation was defined as dsc1&#916; if &lt;1.5 (orange), rbd2&#916; if &gt;3 (pink), and intermediate if in between (blue).</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_6-B</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 6-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Recombinant proteins GST-fused Rbd2 C-terminus (Rbd2200-251), Dsc5 UBX (Dsc5323-425), Dsc2 UBA (Dsc2298-372), and GST-HA-V5 control were bound to GST magnetic beads and incubated with S. pombe cytosol fraction from wild-type cells. Equivalent amounts of unbound and bound fractions were probed for anti-Cdc48, anti-ubiquitin and anti-GSTIgG.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_6-C</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. GSTpulldown assay was performed as in (B) using truncated forms of Rbd2 C-terminus; Rbd2200-251, Rbd2200-225, Rbd2225-251 and Rbd2200-240. Unbound (1x) and bound (5x) fractions were analyzed by western blotting</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_6-D</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Single residue mutants of conserved glycine residues in Rbd2200-251 (G244R and G246R) were tested for Cdc48 binding as in (C). Western blots (B-D) were imaged using chemiluminescence.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_7-A</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Detergent-solubilized yeast extracts from cells containing chromosomal Flag-tagged rbd2 or rbd2-G246R in rbd2&#916; background were prepared, and proteins associated with Rbd2-Flag were immunopurified using anti-Flag magnetic beads. Equal amount of total (lanes 1-3) along with 25x bound fractions (lanes 4-6) were analyzed by western blot with anti-Cdc48 serum and anti-FlagIgG.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_7-C</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 7-C</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Biotin-phenol labeling was performed for 1 min with H2O2 treatment as described in Materials and Methods. WT cells or rbd2&#916; cells carrying rbd2-Flag-APEX2 (rbd2-F-AX) or rbd2-G246R-Flag-APEX2 (G246R-F-AX) plasmid were lysed after biotin-labeling reaction, and proteins were denatured by heating the cells in lysis buffer containing 1%SDS. Biotinylated proteins were then enriched using streptavidin magnetic beads. Lysates and 50x-enriched eluates were analyzed by western blot with IRDye 800CW Streptavidin, anti-Cdc48 serum, or anti-Flag IgG.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_8-A</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Yeast strains (200 cells) containing chromosomal Flag-tagged rbd2, rbd2-G244R, rbd2-G246R or rbd2-S130A in rbd2&#916; background and sre1&#916; yeast were grown on rich medium in the absence or presence of cobalt chloride (CoCl2).</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_8-B</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Western blot of phosphatase-treated, whole cell lysates from strains in (A) grown for 3 hr in the presence or absence of oxygen was probed with anti-Sre1 or anti-Flag IgG. P and N denote Sre1 precursor and cleaved nuclear forms, respectively.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_8-C</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Sre2 cleavage was assayed by western blot using anti-Sre2 serum or anti-Flag IgG of phosphatase-treated, whole cell lysates from the indicated strains. N denotes Sre2 cleaved nuclear form.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_8-D</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 8-D</infon>
    <infon key="sourcedata_figure_dir">Figure_8-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Whole cell lysates from indicated yeast strains carrying a plasmid expressing 3xFlag-Sre2MS were analyzed by western blot with anti-Flag antibody. Two independent isolates, A and B, are shown for each strain. Asterisk denotes non-specific band.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_8-F</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 8-F</infon>
    <infon key="sourcedata_figure_dir">Figure_8-F</infon>
    <passage>
      <offset>0</offset>
      <text>F. Yeast strains containing Flag-tagged rbd2-SHP, rbd2-SHP*, rbd2-G246R-SHP, and rbd2-G246R-SHP* were generated in rbd2&#916; background by chromosomal integration of the rbd2 fusion proteins depicted in (E). Indicated yeast strains were then assayed for Sre1 cleavage as in (B).</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_8-G</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 8-G</infon>
    <infon key="sourcedata_figure_dir">Figure_8-G</infon>
    <passage>
      <offset>0</offset>
      <text>G. Indicated strains were assayed for Sre2 cleavage as in (C).</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_8-H</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 8-H</infon>
    <infon key="sourcedata_figure_dir">Figure_8-H</infon>
    <passage>
      <offset>0</offset>
      <text>H. Wild-type, sre2&#916; or strains containing chromosomal Flag-tagged rbd2, rbd2-G246R or rbd2-S130S in rbd2&#916; background (lane 7-12) were treated with bortezomib (Bz) for 2 hr, and phosphatase-treated, whole cell lysates were analyzed by western blot with anti-Sre2 serum or anti-Flag IgG.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_9-A</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 9-A</infon>
    <infon key="sourcedata_figure_dir">Figure_9-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Western blot of phosphatase-treated whole cell lysates from yeast strains carrying rbd2-Flag-APEX2 (rbd2-F), rbd2-G246R-Flag-APEX2 (G246R) or rbd2-S130A-Flag-APEX2 (S130A) plasmid in rbd2&#916; background and sre1&#916; yeast was probed with anti-Sre1 or anti-Flag IgG. P and N denote Sre1 precursor and cleaved nuclear forms, respectively.</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_9-B</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 9-B</infon>
    <infon key="sourcedata_figure_dir">Figure_9-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Indicated yeast strains (200 cells) containing chromosomal Flag-tagged rbd2, rbd2-G246R or rbd2-S130A in rbd2&#916; background (lane 3-5) or yeast strains (200 cells) carrying rbd2-Flag-APEX2, rbd2-G246R-Flag-APEX2 or rbd2-S130A-Flag-APEX2 plasmid in rbd2&#916; background (lane 6-8) were grown on rich medium in the absence or presence of cobalt chloride (CoCl2).</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_9-C</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 9-C</infon>
    <infon key="sourcedata_figure_dir">Figure_9-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Comparison of Rbd2 protein levels from overexpression system to endogenous expression. Western blot of whole cell lysates from yeast strains containing chromosomal Flag-tagged rbd2, rbd2-G246R or rbd2-S130A in rbd2&#916; background and yeast strains carrying rbd2-Flag-APEX2, rbd2-G246R-Flag-APEX2 or rbd2-S130A-Flag-APEX2 plasmid in rbd2&#916; background was probed with anti-FlagIgG. For quantification, the intensity of Flag band in each lane was normalized to the non-specific band (asterisk).</text>
    </passage>
  </document>
  <document>
    <id>5090219 Figure_9-D</id>
    <infon key="sourcedata_document">2289</infon>
    <infon key="doi">10.15252/embj.201693923</infon>
    <infon key="pmc_id">5090219</infon>
    <infon key="figure">Figure 9-D</infon>
    <infon key="sourcedata_figure_dir">Figure_9-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. rbd2&#916; cells expressing indicated plasmids of GFP-Anp1 or GFP-Sre2MS together with rbd2-Flag-APEX2, rbd2-S130A-Flag-APEX2 or rbd2-S130A/G246R-Flag-APEX2 were treated with Bz at a concentration of 1 mM for 2 hr prior to biotin-labeling reaction. After labeling termination, cells were lysed and denatured as described in Materials and Methods. Biotinylated proteins were then enriched using streptavidin magnetic beads. Lysates (1x input) and 100x-enriched eluates were analyzed by western blot with IRDye 800CW Streptavidin, anti-Flag IgG, anti-Cdc48 serum, and anti-GFP IgG. Intensity of GFP band in enriched sample was normalized to that in the corresponding input sample, then normalized to the Flag intensity in enriched sample. Relative intensities of biotinylated GFP level are shown in bar graph. Error bars denote standard deviation from three biological replicates.</text>
    </passage>
  </document>
</collection>
